|
|
|
Insider
Information: |
Greenstreet Yvonne |
Relationship: |
Chief Executive Office... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
94,840 |
|
Indirect Shares
|
407 |
|
|
Direct
Value |
$20,319,528 |
|
|
Indirect Value
|
$100,529 |
|
|
Total
Shares |
95,247 |
|
|
Total
Value |
$20,420,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-18.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Moelis & Co |
MC |
Director |
2018-11-14 |
1,059 |
2015-02-19 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2022-06-08 |
13,247 |
2015-06-03 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Executive Office... |
2024-06-25 |
80,534 |
2024-06-25 |
407 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
95 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2019-07-11 |
4 |
A |
$0.00 |
$0 |
I/I |
50 |
407 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2019-11-20 |
4 |
OE |
$42.22 |
$354,817 |
D/D |
8,404 |
10,320 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2019-11-20 |
4 |
AS |
$105.00 |
$882,420 |
D/D |
(8,404) |
1,916 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2019-12-12 |
4 |
D |
$120.61 |
$386,917 |
D/D |
(3,208) |
6,208 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
9,416 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-02-07 |
4 |
OE |
$42.22 |
$263,875 |
D/D |
6,250 |
12,458 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-02-07 |
4 |
AS |
$123.90 |
$774,375 |
D/D |
(6,250) |
6,208 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-02-10 |
4 |
OE |
$42.22 |
$236,432 |
D/D |
5,600 |
11,808 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-02-10 |
4 |
AS |
$130.00 |
$1,285,960 |
D/D |
(9,892) |
1,916 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-04-07 |
4 |
D |
$104.75 |
$263,503 |
D/D |
(2,513) |
4,820 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,417 |
7,333 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-05-05 |
4 |
OE |
$42.22 |
$329,780 |
D/D |
7,811 |
12,631 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-05-05 |
4 |
AS |
$140.00 |
$1,093,540 |
D/D |
(7,811) |
4,820 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-05-06 |
4 |
OE |
$77.10 |
$3,855,000 |
D/D |
50,000 |
54,820 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-05-06 |
4 |
AS |
$150.00 |
$7,500,000 |
D/D |
(50,000) |
4,820 |
0 |
% |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,260 |
11,021 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-07-09 |
4 |
OE |
$42.22 |
$484,743 |
D/D |
11,236 |
16,056 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-07-09 |
4 |
AS |
$161.00 |
$1,808,996 |
D/D |
(11,236) |
4,820 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-07-10 |
4 |
OE |
$77.10 |
$3,595,867 |
D/D |
46,639 |
51,459 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Operating Officer |
|
2020-07-10 |
4 |
AS |
$161.00 |
$7,508,879 |
D/D |
(46,639) |
4,820 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
|
2021-01-12 |
4 |
AS |
$161.00 |
$503,125 |
D/D |
(3,125) |
4,820 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
|
2021-01-12 |
4 |
OE |
$42.22 |
$131,938 |
D/D |
3,125 |
7,945 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
|
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,416 |
10,236 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
|
2021-02-12 |
4 |
D |
$155.84 |
$303,403 |
D/D |
(1,945) |
8,291 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
|
2021-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,083 |
13,374 |
0 |
- |
|
95 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|